I received an email asking if I had any information regarding Limu and Alzheimer’s disease. I did a little research and found the information below in the October 2006 issue of Breakthroughs in Health.
Two studies from Canada show that fucoidan may be a potential therapy for Alzheimer’s disease. One study found that fucoidan was able to block amyloid-plaque-induced neurotoxicity. The other found that because fucoidan acts as a complement inhibitor, it could show efficacy against several chronic degenerative-disease processes such as atherosclerosis, myocardial infarction and Alzheimer’s disease.
I would like to thank those of you who have emailed me your questions. I will do my best to find as many answers about Limu as I can.
